141 related articles for article (PubMed ID: 8391117)
1. Characterization of adenosine receptors in human erythroleukemia cells and platelets: further evidence for heterogeneity of adenosine A2 receptor subtypes.
Feoktistov I; Biaggioni I
Mol Pharmacol; 1993 Jun; 43(6):909-14. PubMed ID: 8391117
[TBL] [Abstract][Full Text] [Related]
2. Positive modulation of intracellular Ca2+ levels by adenosine A2b receptors, prostacyclin, and prostaglandin E1 via a cholera toxin-sensitive mechanism in human erythroleukemia cells.
Feoktistov I; Murray JJ; Biaggioni I
Mol Pharmacol; 1994 Jun; 45(6):1160-7. PubMed ID: 8022409
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of A2 adenosine receptor activation. I. Blockade of A2 adenosine receptors by photoaffinity labeling.
Lohse MJ; Klotz KN; Schwabe U
Mol Pharmacol; 1991 Apr; 39(4):517-23. PubMed ID: 2017151
[TBL] [Abstract][Full Text] [Related]
4. Adenosine receptor-adenylate cyclase system in the trout testis: involvement in the regulation of germ cell proliferation.
Loir M
Mol Reprod Dev; 2001 Mar; 58(3):307-17. PubMed ID: 11170272
[TBL] [Abstract][Full Text] [Related]
5. Potent adenosine receptor antagonists that are selective for the A1 receptor subtype.
Martinson EA; Johnson RA; Wells JN
Mol Pharmacol; 1987 Mar; 31(3):247-52. PubMed ID: 3561384
[TBL] [Abstract][Full Text] [Related]
6. Compartmentation of alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells.
McKernan RM; Howard MJ; Motulsky HJ; Insel PA
Mol Pharmacol; 1987 Aug; 32(1):258-65. PubMed ID: 3039340
[TBL] [Abstract][Full Text] [Related]
7. Phorbol ester-stimulated adherence of neutrophils to endothelial cells is reduced by adenosine A2 receptor agonists.
Felsch A; Stöcker K; Borchard U
J Immunol; 1995 Jul; 155(1):333-8. PubMed ID: 7602109
[TBL] [Abstract][Full Text] [Related]
8. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes.
Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Linden J; Cao Z; Murray TF
Vet Immunol Immunopathol; 2008 Jan; 121(1-2):91-100. PubMed ID: 17913243
[TBL] [Abstract][Full Text] [Related]
9. Characterization of adenosine A2 receptors in bovine retinal membranes.
Blazynski C; McIntosh H
Exp Eye Res; 1993 May; 56(5):585-93. PubMed ID: 8500567
[TBL] [Abstract][Full Text] [Related]
10. A1 and A2 adenosine receptor modulation of contractility in the cauda epididymis of the guinea-pig.
Haynes JM; Alexander SP; Hill SJ
Br J Pharmacol; 1998 Oct; 125(3):570-6. PubMed ID: 9806342
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of ATP-induced Ca2+ mobilisation in human retinal pigment epithelial cells.
Collison DJ; Tovell VE; Coombes LJ; Duncan G; Sanderson J
Exp Eye Res; 2005 Apr; 80(4):465-75. PubMed ID: 15781274
[TBL] [Abstract][Full Text] [Related]
12. Binding characteristics of the adenosine A2 receptor ligand [3H]CGS 21680 to human platelet membranes.
Varani K; Borea PA; Guerra L; Dionisotti S; Zocchi C; Ongini E
Biochem Pharmacol; 1994 Oct; 48(8):1658-61. PubMed ID: 7980632
[TBL] [Abstract][Full Text] [Related]
13. Selective blockade and recovery of cell surface alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells. Studies with the irreversible antagonist benextramine.
McKernan RM; Strickland WR; Insel PA
Mol Pharmacol; 1988 Jan; 33(1):51-7. PubMed ID: 2826999
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic evidence for 5-HT1A receptors associated with human retinal pigment epithelial cells in culture.
Nash MS; Osborne NN
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):510-9. PubMed ID: 9040484
[TBL] [Abstract][Full Text] [Related]
15. Adenosine inhibits the rise in intracellular calcium and platelet aggregation produced by thrombin: evidence that both effects are coupled to adenylate cyclase.
Paul S; Feoktistov I; Hollister AS; Robertson D; Biaggioni I
Mol Pharmacol; 1990 Jun; 37(6):870-5. PubMed ID: 2359405
[TBL] [Abstract][Full Text] [Related]
16. 2-Phenylethoxy-9-methyladenine: an adenosine receptor antagonist that discriminates between A2 adenosine receptors in the aorta and the coronary vessels from the guinea pig.
Martin PL; Ueeda M; Olsson RA
J Pharmacol Exp Ther; 1993 Apr; 265(1):248-53. PubMed ID: 8474010
[TBL] [Abstract][Full Text] [Related]
17. Partial separation of platelet and placental adenosine receptors from adenosine A2-like binding protein.
Zolnierowicz S; Work C; Hutchison K; Fox IH
Mol Pharmacol; 1990 Apr; 37(4):554-9. PubMed ID: 2325637
[TBL] [Abstract][Full Text] [Related]
18. Possible heterogeneity of adenosine receptors present on myenteric nerve endings.
Christofi FL; Cook MA
J Pharmacol Exp Ther; 1987 Oct; 243(1):302-9. PubMed ID: 3668861
[TBL] [Abstract][Full Text] [Related]
19. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
Dionisotti S; Ongini E; Zocchi C; Kull B; Arslan G; Fredholm BB
Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of neurotransmitter release from enteric nerve endings by 2-[p-(carboxyethyl)-phenethylamino]-5'-N-ethylcarboxamido-adenosine (CGS-21680) and related adenosine analogs: lack of simple competition by antagonists.
Broad RM; Cook MA
J Pharmacol Exp Ther; 1993 Aug; 266(2):634-41. PubMed ID: 8102645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
